Yesterday, May 26, 2016, 107 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $0.02 to $20,083,643.73.

Highlighted Stocks Traded by Insiders:

Neurocrine Biosciences (NBIX) - FREE Research Report

Pops Richard F, who is Director at Neurocrine Biosciences, sold 15,000 shares at $46.72 on May 26, 2016. Following this transaction, the Director owned 15,464 shares meaning that the stake was reduced by 49.24% with the 15,000-share transaction.

The shares most recently traded at $45.97, down $0.75, or 1.63% since the insider transaction. Historical insider transactions for Neurocrine Biosciences go as follows:

  • 4-Week # shares sold: 15,000
  • 12-Week # shares sold: 15,000
  • 24-Week # shares sold: 15,000

The average volume for Neurocrine Biosciences has been 1.1 million shares per day over the past 30 days. Neurocrine Biosciences has a market cap of $4.0 billion and is part of the health care sector and drugs industry. Shares are down 18.93% year-to-date as of the close of trading on Thursday.

Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. Currently, there are 8 analysts who rate Neurocrine Biosciences a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NBIX - FREE

TheStreet Quant Ratings

rates Neurocrine Biosciences as a

hold

. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and disappointing return on equity. Get the full

Neurocrine Biosciences Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Fiesta Restaurant Group (FRGI) - FREE Research Report

Zirkman Joseph A, who is Svp & Gc at Fiesta Restaurant Group, sold 3,000 shares at $24.50 on May 26, 2016. Following this transaction, the Svp & Gc owned 124,423 shares meaning that the stake was reduced by 2.35% with the 3,000-share transaction.

The shares most recently traded at $24.82, up $0.32, or 1.29% since the insider transaction. Historical insider transactions for Fiesta Restaurant Group go as follows:

  • 4-Week # shares bought: 3,000
  • 4-Week # shares sold: 3,936
  • 12-Week # shares bought: 3,000
  • 12-Week # shares sold: 3,936
  • 24-Week # shares bought: 3,000
  • 24-Week # shares sold: 3,936

The average volume for Fiesta Restaurant Group has been 501,000 shares per day over the past 30 days. Fiesta Restaurant Group has a market cap of $666.0 million and is part of the services sector and leisure industry. Shares are down 27.14% year-to-date as of the close of trading on Thursday.

Fiesta Restaurant Group, Inc., through its subsidiaries, owns, operates, and franchises fast-casual restaurants. It operates its fast-casual restaurants under the Pollo Tropical and Taco Cabana brand names. The company has a P/E ratio of 17.0. Currently, there are 5 analysts who rate Fiesta Restaurant Group a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on FRGI - FREE

TheStreet Quant Ratings

rates Fiesta Restaurant Group as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, poor profit margins and a generally disappointing performance in the stock itself. Get the full

Fiesta Restaurant Group Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Lakeland Bancorp (LBAI) - FREE Research Report

Matteson Timothy J, who is EVP and General Counsel at Lakeland Bancorp, sold 4,500 shares at $11.41 on May 26, 2016. Following this transaction, the EVP and General Counsel owned 28,440 shares meaning that the stake was reduced by 13.66% with the 4,500-share transaction.

The shares most recently traded at $11.39, down $0.02, or 0.18% since the insider transaction. Historical insider transactions for Lakeland Bancorp go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 2,000
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 2,000
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 2,000

The average volume for Lakeland Bancorp has been 75,900 shares per day over the past 30 days. Lakeland Bancorp has a market cap of $471.4 million and is part of the financial sector and banking industry. Shares are down 3.73% year-to-date as of the close of trading on Thursday.

Lakeland Bancorp, Inc. operates as the holding company for Lakeland Bank that provides financial products and services for individuals and small to medium sized businesses primarily in Northern and Central New Jersey. The stock currently has a dividend yield of 3.31%. The company has a P/E ratio of 13.8. Currently, there are 2 analysts who rate Lakeland Bancorp a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LBAI - FREE

TheStreet Quant Ratings

rates Lakeland Bancorp as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins and attractive valuation levels. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full

Lakeland Bancorp Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.